Chile vs Estonia: Reported rate of new cervical cancer cases
Chile
16.68 per 100,000 women
in 2017
Estonia
13.75 per 100,000 women
in 2017
Chile rank
3rd
Estonia rank
6th
Reported rate of new cervical cancer cases over time
- Chile
- Estonia
How they compare
Chile currently reports 16.68 per 100,000 women against 13.75 per 100,000 women in Estonia, a difference of 2.93 per 100,000 women.
That makes Chile's figure about 1.2 times Estonia's.
The two have swapped places 4 times across 20 shared years of data; in 1998 it was Chile ahead.
Chile ranks 3rd and Estonia ranks 6th of 46 countries.
Across the 3 decades both report, Chile averaged higher in 2 and Estonia in 1.
Head to head by decade
| Decade | Chile | Estonia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 22.15 per 100,000 women | 14.45 per 100,000 women | 7.7 per 100,000 women | Chile |
| 2000s | 17.54 per 100,000 women | 16.5 per 100,000 women | 1.05 per 100,000 women | Chile |
| 2010s | 12.75 per 100,000 women | 15.99 per 100,000 women | 3.24 per 100,000 women | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Chile or Estonia?
- Chile, at 16.68 per 100,000 women against 13.75 per 100,000 women in Estonia as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Chile and Estonia?
- 2.93 per 100,000 women, with Chile ahead.
- How many years of comparable data are there for Chile and Estonia?
- 20 years are reported by both, from 1998 to 2017.
- How do Chile and Estonia rank globally for reported rate of new cervical cancer cases?
- Chile ranks 3rd and Estonia ranks 6th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) β processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.